Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

NYSE:CNK - New York Stock Exchange, Inc. - US17243V1026 - Common Stock - Currency: USD

29.8  -0.05 (-0.17%)

After market: 29.8 0 (0%)

Fundamental Rating

5

CNK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. CNK scores excellent on profitability, but there are concerns on its financial health. CNK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CNK was profitable.
In the past year CNK had a positive cash flow from operations.
In multiple years CNK reported negative net income over the last 5 years.
CNK had a positive operating cash flow in 4 of the past 5 years.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK has a Return On Assets of 5.16%. This is amongst the best in the industry. CNK outperforms 83.33% of its industry peers.
CNK has a better Return On Equity (69.13%) than 95.83% of its industry peers.
With an excellent Return On Invested Capital value of 7.83%, CNK belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CNK is significantly below the industry average of 22.90%.
The last Return On Invested Capital (7.83%) for CNK is above the 3 year average (5.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROIC 7.83%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

CNK's Profit Margin of 8.02% is amongst the best of the industry. CNK outperforms 84.72% of its industry peers.
CNK's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 10.66%, CNK belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
CNK's Operating Margin has been stable in the last couple of years.
The Gross Margin of CNK (64.38%) is better than 73.61% of its industry peers.
CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNK is still creating some value.
The number of shares outstanding for CNK has been increased compared to 1 year ago.
The number of shares outstanding for CNK has been increased compared to 5 years ago.
CNK has a better debt/assets ratio than last year.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that CNK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.22, CNK perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
The Debt to FCF ratio of CNK is 11.16, which is on the high side as it means it would take CNK, 11.16 years of fcf income to pay off all of its debts.
CNK has a Debt to FCF ratio (11.16) which is in line with its industry peers.
CNK has a Debt/Equity ratio of 5.66. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.66, CNK is doing worse than 76.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Altman-Z 1.22
ROIC/WACC1.01
WACC7.77%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.79 indicates that CNK may have some problems paying its short term obligations.
CNK has a Current ratio (0.79) which is comparable to the rest of the industry.
CNK has a Quick Ratio of 0.79. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.76, CNK perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.76
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

CNK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.83%.
Measured over the past 5 years, CNK shows a small growth in Earnings Per Share. The EPS has been growing by 4.49% on average per year.
The Revenue has decreased by -0.80% in the past year.
CNK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.47% yearly.
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%

3.2 Future

CNK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.85% yearly.
CNK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.68% yearly.
EPS Next Y-13.93%
EPS Next 2Y7.46%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.61, which indicates a rather expensive current valuation of CNK.
Based on the Price/Earnings ratio, CNK is valued cheaper than 84.72% of the companies in the same industry.
When comparing the Price/Earnings ratio of CNK to the average of the S&P500 Index (27.30), we can say CNK is valued slightly cheaper.
The Price/Forward Earnings ratio is 12.71, which indicates a correct valuation of CNK.
90.28% of the companies in the same industry are more expensive than CNK, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CNK is valued a bit cheaper.
Industry RankSector Rank
PE 19.61
Fwd PE 12.71
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNK is valued cheaper than 80.56% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CNK is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.56
EV/EBITDA 10.01
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CNK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.37
EPS Next 2Y7.46%
EPS Next 3Y9.85%

3

5. Dividend

5.1 Amount

CNK has a Yearly Dividend Yield of 1.04%.
Compared to an average industry Dividend Yield of 6.55, CNK pays a better dividend. On top of this CNK pays more dividend than 86.11% of the companies listed in the same industry.
With a Dividend Yield of 1.04, CNK pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.04%

5.2 History

CNK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y7.46%
EPS Next 3Y9.85%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (7/11/2025, 8:04:00 PM)

After market: 29.8 0 (0%)

29.8

-0.05 (-0.17%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners122.04%
Inst Owner Change0%
Ins Owners2.11%
Ins Owner Change-5.79%
Market Cap3.43B
Analysts75
Price Target33.94 (13.89%)
Short Float %24.9%
Short Ratio6.48
Dividend
Industry RankSector Rank
Dividend Yield 1.04%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date05-29 2025-05-29 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.93%
Min EPS beat(2)-100.53%
Max EPS beat(2)-13.33%
EPS beat(4)2
Avg EPS beat(4)62.52%
Min EPS beat(4)-100.53%
Max EPS beat(4)254.24%
EPS beat(8)5
Avg EPS beat(8)64.97%
EPS beat(12)6
Avg EPS beat(12)-8.2%
EPS beat(16)7
Avg EPS beat(16)1.09%
Revenue beat(2)1
Avg Revenue beat(2)0.74%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)2.45%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)5.09%
Revenue beat(8)7
Avg Revenue beat(8)2.96%
Revenue beat(12)10
Avg Revenue beat(12)2.73%
Revenue beat(16)13
Avg Revenue beat(16)6.14%
PT rev (1m)1.44%
PT rev (3m)2.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.49%
EPS NY rev (1m)4.99%
EPS NY rev (3m)-2.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 19.61
Fwd PE 12.71
P/S 1.14
P/FCF 15.56
P/OCF 9.27
P/B 9.81
P/tB N/A
EV/EBITDA 10.01
EPS(TTM)1.52
EY5.1%
EPS(NY)2.34
Fwd EY7.87%
FCF(TTM)1.91
FCFY6.42%
OCF(TTM)3.21
OCFY10.78%
SpS26.18
BVpS3.04
TBVpS-10.38
PEG (NY)N/A
PEG (5Y)4.37
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 69.13%
ROCE 9.05%
ROIC 7.83%
ROICexc 9.75%
ROICexgc 21.27%
OM 10.66%
PM (TTM) 8.02%
GM 64.38%
FCFM 7.31%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 5.66
Debt/FCF 11.16
Debt/EBITDA 3.81
Cap/Depr 75.61%
Cap/Sales 4.96%
Interest Coverage 2.19
Cash Conversion 71.26%
Profit Quality 91.22%
Current Ratio 0.79
Quick Ratio 0.76
Altman-Z 1.22
F-Score6
WACC7.77%
ROIC/WACC1.01
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%-268.42%
EPS Next Y-13.93%
EPS Next 2Y7.46%
EPS Next 3Y9.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%-6.65%
Revenue Next Year9.46%
Revenue Next 2Y8.36%
Revenue Next 3Y6.68%
Revenue Next 5YN/A
EBIT growth 1Y-10.88%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year81.21%
EBIT Next 3Y29.04%
EBIT Next 5YN/A
FCF growth 1Y52.49%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y40.69%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%